SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.
This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.
See the Speakers and Southeast Asia Team Below:
